The increasing prevalence of cancer is expected to drive the growth of the global interventional oncology devices market in the forecast period, 2024-2028F.
According to TechSci Research report, “Interventional Oncology Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F”, Global interventional oncology devices market is anticipated to grow at an impressive rate in the forecast period, 2024-2028. This can be ascribed to the increasing demand for minimally invasive procedures for the treatment of different types of cancer advantages of using this device for a shorter hospital stay, minimal risk of infection, cause less pain, and faster recovery time in comparison to other surgeries across the globe is expected to create lucrative opportunities for the market growth in coming years. Besides, the availability of private and government funding for research and development activities in cancer disease is further expected to support the market growth. Similarly, the availability of skilled professionals for helping patients as well as using the devices is expected to boost the market growth during the forecast period. Additionally, government and private organizations are taking initiative and investing in the medical sector for the development of better healthcare infrastructure in the underdeveloped regions along with favorable reimbursement procedures will boost the market growth during the forecast period. However, the scarcity of skilled lab professionals to run the diagnostics tests tend to slow down the growth of the global interventional oncology devices market in the forecast period. Similarly, inadequate distribution of funds for the research purpose in academic and research institutes along with limited operations in most of the industries, because of temporary lockdown of academic institutes, and manufacturers, can further restrict the growth of the global interventional oncology devices market. Additionally, lack of awareness about new technology for the treatment of cancer in the developing region along with rising product recall is also hampering the market growth during the forecast period.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Interventional Oncology Devices Market"
The global interventional oncology devices market can be segmented by product, procedure, cancer type, and by region.
Based on product, the global interventional oncology devices market can be segmented into Embolization Devices, Ablation Devices, and Support Devices. The embolization devices segment dominated the market in 2022 and is expected to continue maintaining its dominance throughout the forecast period. This can be ascribed to the increasing preference of patients and healthcare professionals towards minimally invasive treatment because it provides immediate relief, less blood loss, less risk and is cost-effective.
Based on cancer type, the market can be segmented into Liver, Kidney, Lung, Bone, and Others. The lung cancer segment is expected to dominate during the forecast period on account of increasing number of patients suffering from lung cancer and growing habit of smoking among the young generation across the globe.
Major companies operating in the global interventional oncology devices market are:
- Medtronic plc.
- Terumo Corporation.
- Merit Medical Systems, Inc.
- Philips Volcano.
- Johnson & Johnson
- Teleflex Inc.
- Angiodynamics Inc.
- Becton, Dickinson and Company.
Now, researchers from Stanford University have created a small wearable device capable of measuring size changes in cancerous tumors under the skin.
The therascreen EGFR RGQ PCR Kit version 2 is a molecular diagnostic kit for detection of exon 19 deletions, L858R, L861Q, G719X, S768I, exon 20 insertions, and the resistance mutation T790M in the EGFR gene using real-time PCR on the Rotor-Gene Q 5plex HRM instrument.
Customers can also request for 10% free customization on this report.
“North America is expected to dominate in the global interventional oncology devices market due to the increasing prevalence of cancer, growing geriatric population, increasing development of better healthcare, and rising adoption of advanced treatments across the region. Furthermore, the increasing developments in new technology along with rising government investments in healthcare, and rapid adoption of new technology among patients and healthcare providers, are expected to create lucrative growth during the forecast period. Besides, the availability of skilled professionals and increasing demand for minimally invasive procedures in hospitals and clinics in the region are further expected to create lucrative opportunities for the market growth” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Interventional Oncology Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented By Product (Embolization Devices, Ablation Devices, Support Devices), By Procedure (Thermal Tumor Ablation, Non-thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Transcatheter Arterial Embolization (TAE)), By Cancer Type (Liver, Kidney, Lung, Bone, Others) and By Region”, has evaluated the future growth potential of global interventional oncology devices market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global interventional oncology devices market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com
Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reportsThe Interventional Oncology Devices Global Market Report 2020-30 by The Business Research Company describes and explains the global interventional oncology devices market and covers 2015 to 2020, termed the historic period, and 2020 to 2025, termed the forecast period, along with further forecasts for the period 2025-2030.
The report evaluates the market across each region and for the major economies within each region.The Interventional Oncology Devices Global Market Report 2021 covers interventional oncology devices market drivers, interventional oncology devices market trends, interventional oncology devices market segments, interventional oncology devices market growth rate, interventional oncology devices market major players, and interventional oncology devices market size.View Complete Report: https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report-2020-30-covid-19-growth-and-changeThe interventional oncology devices market report provides an in-depth analysis of the impact of COVID-19 on the global interventional oncology devices industry, along with revised market numbers due to the effects of the coronavirus and the expected interventional oncology devices market growth numbers 2021-2030.Interventional Oncology Devices Global Market Report 2021 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
The chapter also covers markets which have been positively affected by the pandemic.Request For The Sample Now:https://www.thebusinessresearchcompany.com/sample.aspx?id=3304=smpThe global interventional oncology devices market is expected to grow from $2.015 billion in 2020 to $2.234 billion in 2021 at a compound annual growth rate (CAGR) of 10.9%.
The market is expected to reach $3.32 billion in 2025 at a CAGR of 10%.The report covers the interventional oncology device market segments-1) By Product: Embolization Devices, Ablation Devices, Support Devices.2) By Procedure: Thermal Tumor Ablation, Non-thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE) Or Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE) Or Bland Embolization.3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Others.About The Business Research Company: The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research.
It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally.
Interventional Oncology Devices market research report proves to be an absolute solution to have exclusive market research data that suits business needs.
It guides companies to take significant actions to deal with threats in the niche market.
Market segmentation covered here is actually based on various parameters such as type of product, its components, type of management and geography.
This Interventional Oncology Devices market report endows with the numerous insights and business solutions that will aid to stand high in the competition.
The consistent and extensive market information of this report will definitely help grow business and improve return on investment (ROI).Interventional oncology devices market is expected to gain market growth in the forecast period of 2021 to 2028.
Data Bridge Market Research analyses the market to account to USD 3.75 billion by 2028 and will grow at a CAGR of 6.95% in the above mentioned forecast period.With the use of various reliable sources such as journals, websites, annual reports of the companies, and mergers, the data and information mentioned in this Interventional Oncology Devices report has been gathered.
The Business Research Company published its Interventional Oncology Devices Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Interventional Oncology Devices market.
The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.The report covers the Interventional Oncology Devices market’s segments-1) By Product: Embolization Devices, Ablation Devices, Support Devices2) By Procedure: Thermal Tumor Ablation, Non-thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE) or Bland Embolization3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Others.View Complete Report:https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report-2020-30-covid-19-growth-and-changeInterventional Oncology Devices Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
The chapter also covers markets which have been positively affected by the pandemic.The global interventional oncology device market is expected to decline from $2.13 billion in 2019 to $2.01 billion in 2020 at a compound annual growth rate (CAGR) of -5.39%.
The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities.
The entire supply chain has been disrupted, impacting the market negatively.
